Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Chronic Heart Failure

Free Subscription 09.02.2026 2 Am J Cardiol 1 BMJ 5 Cardiovasc Res 1 Circ Genom Precis Med 2 Circ Heart Fail 1 Circulation 3 Eur Heart J 1 Heart 1 Int J Cardiol 1 J Card Fail 3 J Cardiol 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Cardiol

1. YADALAM AK, Desai SR, Razavi AC, Gold ME, et al
   Safety and Tolerability of Short-Term Oral Triiodothyronine in Euthyroid Patients with Ischemic Heart Failure: A Phase I, Open-Label, Controlled Clinical Trial.
   Am J Cardiol. 2026 Feb 1:S0002-9149(26)00032.
   PubMed        
   
   
2. MILARAS N, Pamporis K, Gatzoulis K, Karakasis P, et al
   The Nondilated Left Ventricular Cardiomyopathy Phenotype: Arrhythmic Prognosis and Differences With Dilated Cardiomyopathy.
   Am J Cardiol. 2026;262:35-44.
   PubMed         Abstract available
   
   

   
   BMJ

3. WISE J
   Heart failure: Paperclip sized monitor for home use is approved by NICE.
   BMJ. 2026;392:s242.
   PubMed        
   
   

   
   Cardiovasc Res

4. PAN Q, Chen C, Zhang C, Jiang Y, et al
   Small extracellular vesicle-mediated adipocyte-cardiomyocyte crosstalk exacerbates heart failure with preserved ejection fraction.
   Cardiovasc Res. 2026 Feb 5:cvag030. doi: 10.1093.
   PubMed         Abstract available
   
   
5. KLEINBONGARD P, Beyer AM
   Telomer length, integrity vs. telomerase-activity - who is to blame for heart failure?
   Cardiovasc Res. 2026 Feb 3:cvag026. doi: 10.1093.
   PubMed        
   
   
6. HEGNER P, Baier MJ, Krammer T, Seitz S, et al
   Semaglutide improves contractile function in human atrial myocardium of patients with heart failure and preserved ejection fraction.
   Cardiovasc Res. 2026 Feb 3:cvag039. doi: 10.1093.
   PubMed        
   
   
7. NAH J, Sung EA, Zhai P, Maejima Y, et al
   Cardiomyocyte-specific deficiency of C/EBPbeta aggravates pressure overload-induced heart failure.
   Cardiovasc Res. 2026 Jan 30:cvag029. doi: 10.1093.
   PubMed         Abstract available
   
   
8. KARAMPINOS KI, Farmakis D, Gurung R, Foo RS, et al
   Ferroptosis in heart failure: from molecular insights to therapeutic implications.
   Cardiovasc Res. 2026 Jan 31:cvag019. doi: 10.1093.
   PubMed         Abstract available
   
   

   
   Circ Genom Precis Med

9. NJOROGE JN, Sanders van Wijk S, Austin TR, Brody JA, et al
   Large-Scale Proteomic Profiling of Incident Heart Failure and Its Subtypes in Older Adults.
   Circ Genom Precis Med. 2026 Feb 4:e005031. doi: 10.1161/CIRCGEN.124.005031.
   PubMed         Abstract available
   
   

   
   Circ Heart Fail

10. BANSAL N
    Expanding the Lens on Heart Failure Risk Stratification.
    Circ Heart Fail. 2026 Feb 5:e014170. doi: 10.1161/CIRCHEARTFAILURE.126.014170.
    PubMed        
    
    
11. PEIKERT A, Vacca A, Norata GD, Schiattarella GG, et al
    Cellular Interactions and Immunometabolic Mechanisms in Heart Failure With Preserved Ejection Fraction: From Molecular Mechanisms to Clinical Evidence.
    Circ Heart Fail. 2026 Feb 2:e012674. doi: 10.1161/CIRCHEARTFAILURE.125.012674.
    PubMed         Abstract available
    
    

    
    Circulation

12. PAN T, Liu T, Jiang C, Yu X, et al
    Insulin Resistance Compromises the Pentose Phosphate Pathway and Impairs Left Ventricular Assist Device-Mediated Myocardial Recovery in Obese Patients with Heart Failure.
    Circulation. 2026 Feb 6. doi: 10.1161/CIRCULATIONAHA.124.072850.
    PubMed         Abstract available
    
    

    
    Eur Heart J

13. KRANTZ MJ, Senatore F, Psotka MA, Fiuzat M, et al
    Heart Failure Endpoints in FDA Pivotal Trials.
    Eur Heart J. 2026 Jan 30:ehag069. doi: 10.1093.
    PubMed         Abstract available
    
    
14. MAEGAARD ERIKSEN V, Lim CW, Thuraiaiyah J, Bjerre Tarp J, et al
    Heart failure with preserved ejection fraction in adults with congenital heart disease.
    Eur Heart J. 2026 Jan 30:ehag017. doi: 10.1093.
    PubMed         Abstract available
    
    
15. BAPTISTA R, Rodrigues AM, Bernardo F, Mendes LL, et al
    Heart failure in the Portuguese population aged >/=50 years: prevalence and phenotypes in the PORTHOS study.
    Eur Heart J. 2026 Feb 5:ehag030. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Heart

16. VERELST F, Witte KK, Ahmed FZ, Al-Khatib SM, et al
    Atrial fibrillation and heart failure with preserved ejection fraction: diagnostic challenges and therapeutic opportunities.
    Heart. 2026 Feb 5:heartjnl-2025-326954. doi: 10.1136/heartjnl-2025-326954.
    PubMed         Abstract available
    
    

    
    Int J Cardiol

17. KANDIAH A, Taraldsen IA, El-Sheikh M, El Caidi NO, et al
    Prevalence and prognostic value of elevated soluble urokinase plasminogen activator receptor (suPAR) in patients admitted with acute heart failure.
    Int J Cardiol. 2026;449:134199.
    PubMed         Abstract available
    
    

    
    J Card Fail

18. WEI S, McConnell ES, Corazzini KN, Moody J, et al
    Hidden Structure of Care Coordination in Heart Failure Care Transitions: A Mixed-method Network Analysis of Clinical Notes.
    J Card Fail. 2026 Jan 31:S1071-9164(26)00001.
    PubMed         Abstract available
    
    

    
    J Cardiol

19. TAMURA K, Umehara T, Kimura T, Miyamaru T, et al
    Physical functions and nutritional status are influenced by the readmission period in patients with heart failure: A scoping review.
    J Cardiol. 2026 Feb 4:S0914-5087(26)00022-5. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    
20. HARADA T, Kagami K, Ishii H, Obokata M, et al
    Early diagnosis of heart failure with preserved ejection fraction: From primary care screening to invasive hemodynamic confirmation.
    J Cardiol. 2026 Feb 4:S0914-5087(26)00025-0. doi: 10.1016/j.jjcc.2026.
    PubMed         Abstract available
    
    
21. YI JE, Cho JS
    Artificial intelligence in HFpEF: Diagnosis, prognosis, and management strategies.
    J Cardiol. 2026;87:113-120.
    PubMed         Abstract available
    
    

    
    PLoS One

22. GARIN N, Carballo D, Dash J, Stirnemann J, et al
    Overweight and obesity association with mortality in patients with heart failure and reduced or preserved ejection fraction-a cohort study.
    PLoS One. 2026;21:e0341606.
    PubMed         Abstract available
    
    
23. WAGNER M, Rottlander D, Voss S, Brinks R, et al
    Estimating the incidence of heart failure: Insights from an illness-death model using statutory health insurance data from 70 million people in Germany.
    PLoS One. 2026;21:e0341810.
    PubMed         Abstract available
    
    
24. WOLF MJ, El Moghrabi S, Palacios-Ramirez R, Bamberg K, et al
    The novel mineralocorticoid receptor modulator balcinrenone protects against diet-induced cardiac microvascular dysfunction and plasma potassium elevation in mouse models.
    PLoS One. 2026;21:e0341078.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum